• Valentina Marziali, Georgios Geropoulos, Luca Frasca, Filippo Longo, Davide Patrini, Nikolaos Panagiotopoulos, and Pierfilippo Crucitti.
• Department of Thoracic Surgery, University Campus Bio-Medico, Via Alvaro Del Portillo 21, Rome, 00128, Italy. Electronic address: vale.marziali95@gmail.com.
• Respir Med. 2020 Jul 1; 168: 105995.

IntroductionBrit-Hogg-Dubé syndrome (BHD) is a rare disorder that is estimated to affects about 600 families in the World. The disease-causing mutations is on FLCN gene which codes for folliculin. This protein has a role in different organs as skin, kidney and lung, thanks to the interaction with type I and II cadherins, RhoA activity and the regulation of AMPK, mTORC1 pathways and cell adhesion. The aim of our study is to focus on the manifestation of the syndrome, especially the pulmonary involvement, then on genetical analysis and on the available treatments.Material And MethodsWe collected 15 previous studies where we found medical history information, clinical manifestations, radiological and histological diagnosis and genetical analysis.ResultsThe prevalence of pneumothorax in patients with BHD syndrome was about 65%, but the lung involvement with multiple small cysts, localized especially in the lower part, was 85%. The prevalence of renal involvement in BHD patients ranged from 6.5% to 34%, while skin lesions ranged from 11% to 50%. More than 150 FLCN germline has been described, though the mutation in exon 11 is the most frequently detected, especially among Caucasian population.ConclusionsBHD syndrome is rare and usually the first manifestations appear in early age. In patients with these clinical and radiological characteristics we suggest taking a careful medical history, though the diagnosis of BHD syndrome should be confirmed with the analysis of FLCN gene.Copyright © 2020 Elsevier Ltd. All rights reserved.

26 keywords...

hide…